Vascular Endothelial Growth Factor (VEGF165) Plasma Level Increase with Immunodepression in AIDS Patients with Kaposi's Sarcoma
- 31 March 1999
- journal article
- research article
- Published by Elsevier in Microvascular Research
- Vol. 57 (2) , 208-210
- https://doi.org/10.1006/mvre.1998.2129
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cellsPublished by Elsevier ,2004
- Vascular endothelial growth factor is a potent angiogenic factor in AIDS-associated Kaposi's sarcoma-derived spindle cells.The Journal of Immunology, 1997
- Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS–Kaposi sarcomaProceedings of the National Academy of Sciences, 1997
- Involvement of Vascular Endothelial Growth Factor in Kaposi's Sarcoma Associated with Acquired Immunodeficiency SyndromeJapanese Journal of Cancer Research, 1996
- Identification of a Natural Soluble Form of the Vascular Endothelial Growth Factor Receptor, FLT-1, and Its Heterodimerization with KDRBiochemical and Biophysical Research Communications, 1996
- Vascular permeability factor (VPF, VEGF) in tumor biologyCancer and Metastasis Reviews, 1993
- The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth FactorScience, 1992
- Fibroblast growth factors: broad spectrum mitogens with potent angiogenic activityTrends in Biochemical Sciences, 1986